Amedeo Smart

Free Medical Literature Service


 

Amedeo

Prostate Cancer

  Free Subscription

22.09.2025

1 Am J Surg Pathol
1 Br J Cancer
2 Clin Imaging
2 Int J Cancer
2 Int J Urol
1 J Magn Reson Imaging
1 Nat Rev Urol
1 PLoS One
1 Prostate
1 Urology



    Am J Surg Pathol

  1. ZONG Y, Sharobim M, Lawrence EM, Hu R, et al
    Psammomatous Calcifications Identified in Targeted Needle Biopsies and Radical Prostatectomy From IDH1 Mutant Prostatic Adenocarcinoma : Case Report and Literature Review.
    Am J Surg Pathol. 2025;49:1090-1096.
    >> Share


    Br J Cancer

  2. MAY M, Gilfrich C, Enzinger B, Brookman-May S, et al
    Exercise oncology in prostate cancer: from observational insight to prescriptive precision.
    Br J Cancer. 2025 Sep 16. doi: 10.1038/s41416-025-03205.
    >> Share


    Clin Imaging

  3. SIMON BD, Harmon SA, Turkbey B
    Reply to "A critical appraisal and methodological inquiry into an automated multimodal deep learning model for predicting biochemical recurrence in prostate cancer".
    Clin Imaging. 2025 Sep 13:110616. doi: 10.1016/j.clinimag.2025.110616.
    >> Share

  4. APHALE P, Dokania S, Shekhar H
    A critical appraisal and methodological inquiry into an automated multimodal deep learning model for predicting biochemical recurrence in prostate cancer.
    Clin Imaging. 2025 Sep 11:110615. doi: 10.1016/j.clinimag.2025.110615.
    >> Share


    Int J Cancer

  5. SANTIAGO LR, Ladoukakis E, Scibior-Bentkowska D, Nedjai B, et al
    Polygenic risk score and prostate specific antigen predict death from prostate cancer in men with intermediate aggressive cancer.
    Int J Cancer. 2025 Sep 16. doi: 10.1002/ijc.70163.
    >> Share

  6. CHOPRA R, Li H, Xie W, Lam DHT, et al
    Arrhythmic expression signatures of circadian clock-associated transcription factors and chronic circadian disruption contribute to advanced prostate cancer growth.
    Int J Cancer. 2025 Sep 15. doi: 10.1002/ijc.70149.
    >> Share


    Int J Urol

  7. HATANO K
    Editorial Comment on "Nomogram for Predicting the Survival Outcome of Cabazitaxel Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer: A Multi-Institutional Analysis".
    Int J Urol. 2025 Sep 17. doi: 10.1111/iju.70236.
    >> Share

  8. NAKAJIMA Y, Hashimoto K, Shindo T, Kobayashi K, et al
    Prostate-Specific Antigen Dynamics and Bone Predominance as Predictors of Efficacy in Radium-223 Treatment for Castration-Resistant Prostate Cancer.
    Int J Urol. 2025 Sep 16. doi: 10.1111/iju.70229.
    >> Share


    J Magn Reson Imaging

  9. SUNDARAM KM, Sagreiya H, Rosen MA
    Editorial for "Preoperative Assessment of Extraprostatic Extension in Prostate Cancer Using an Interpretable Tabular Prior-Data Fitted Network-Based Radiomics Model From MRI".
    J Magn Reson Imaging. 2025 Sep 13. doi: 10.1002/jmri.70115.
    >> Share


    Nat Rev Urol

  10. HENNES D, Al-Khanaty A, Chen DC, Dinneen E, et al
    End of the TRUS era: transperineal biopsy takes the lead in prostate cancer detection.
    Nat Rev Urol. 2025 Sep 15. doi: 10.1038/s41585-025-01090.
    >> Share


    PLoS One

  11. WANG W, Xie G, Wu Z
    Development of a prostate cancer biochemical recurrence risk signature using machine learning and motor protein-related genes.
    PLoS One. 2025;20:e0332747.
    >> Share


    Prostate


  12. Correction to "Resveratrol Inhibits the Tumor Migration and Invasion by Upregulating TET1 and Reducing TIMP2/3 Methylation In Prostate Carcinoma Cells".
    Prostate. 2025 Sep 14. doi: 10.1002/pros.70047.
    >> Share


    Urology

  13. SLOTA J, Naser-Tavakolian A, Ji E, Driscoll C, et al
    Economic Burden of Urinary Incontinence in Men with Prostate Cancer: Results from the Medical Expenditure Panel Survey (2016-2021).
    Urology. 2025 Sep 12:S0090-4295(25)00884-2. doi: 10.1016/j.urology.2025.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016